Last reviewed · How we verify
NCT02898090: PACHA
Development and Validation of Automated Indicators on the Appropriateness of Oral Anticoagulant Prescriptions
trial in Healthcare Quality Indicators in 1,213 participants. Completed in 1 February 2022.
1 February 2022
Quick facts
| Lead sponsor | University Hospital, Bordeaux |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,213 |
| Start date | 28 April 2018 |
| Primary completion | 1 February 2022 |
| Estimated completion | 1 February 2022 |
| Sites | 4 locations across France |
Conditions studied
- Healthcare Quality Indicators — all drugs for Healthcare Quality Indicators →
- Inappropriate Prescribing — all drugs for Inappropriate Prescribing →
- Anticoagulant Drugs — all drugs for Anticoagulant Drugs →
- Atrial Fibrillation — all drugs for Atrial Fibrillation →
Sponsor
University Hospital, Bordeaux
Who can join
18 and older, any sex, with Healthcare Quality Indicators or Inappropriate Prescribing. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This research focuses on the development and validation of indicators on the appropriateness of oral anticoagulant prescriptions. The investigators want to propose transferable tools to other healthcare institutions to allow automated construction of indicators as part of a structured approach to improve future practices. The main objective of the study is to develop indicators on the appropriateness of oral anticoagulant prescriptions in adult medicine automated from the hospital information system and to assess their criterion validity.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Development and validation of hospital information system-generated indicators of the appropriateness of oral anticoagulant prescriptions in hospitalised adults: the PACHA study protocol.
Petit-Monéger A, Thiessard F, Jouhet V, Noize P, et al · · 2017 · cited 2× · PMID 28860229 · DOI 10.1136/bmjopen-2017-016488
Verify or expand the search:
- PubMed search for NCT02898090
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University Hospital, Bordeaux trials
Trials by the same sponsor.
- NCT07506928 — NEURO - Prognostication Using Late Somatosensory Evoked - Potentials · NA · not yet recruiting
- NCT07524036 — Impact of a Nursing Educational Consultation on the Patient's Adherence to Their Post-stroke Care Plan. · NA · not yet recruiting
- NCT07527494 — Digital MEDIcal TWIN for the Prediction of Arrhythmic Sudden Cardiac Death After a Myocardial Infarction · NA · not yet recruiting
- NCT07527442 — Efficacy and Safety of Circumcision Alone on Risk of Febrile Urinary Tract Infections in Boys With Posterior Urethral Va · Phase 2 · not yet recruiting
- NCT07478523 — FAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02898090 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Bordeaux
- Last refreshed: 27 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02898090.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing